Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:SM 44:6;O3)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003717 AN006098 Lipidomics analysis of mouse pancreatic cancer cells cultured RPMI, TIFM, or TIFM + arginine under lipid deprivation Cultured cells Mouse Cancer University of Chicago LC-MS
ST003715 AN006096 Lipidomics analysis of mouse PDAC cell lines treated with tung oil Cultured cells Mouse Cancer University of Chicago LC-MS
ST003714 AN006095 Lipidomics analysis of mouse PDAC cell lines treated with alpha-eleostearic acid Cultured cells Mouse Cancer University of Chicago LC-MS
ST003103 AN005077 Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach Blood Human COVID-19 Universidad CEU San Pablo GC-MS/LC-MS
  logo